Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

Completed · Phase 1

Conditions studied: Type2 Diabetes Mellitus

In brief

The purpose of this study is to examine the drug-drug interaction in your body when given the study drug, bexagliflozin, with three commonly used ant-diabetic medications, metformin, glimepiride or sitagliptin. The study will also evaluate how safe the study drug is and how well the study drug is tolerated when taken with metformin, glimepiride or sitagliptin.

Key facts

Study ID
NCT02956044
Run by
Theracos
People needed
54
Starts
2016-11-01
Expected to finish
2017-03-01
Last updated by the study team
2021-07-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.